Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1β and tumor necrosis factor-α, but is upregulated by interleukin-6

This publication has 20 references indexed in Scilit:

• Proinflammatory Cytokines But Not Acute Phase Serum Amyloid A Or C-Reactive Protein, Downregulate Paraoxonase 1 (Pon1) Expression By Hepg2 Cells
  Amyloid, 2002
• Oxidized Phospholipids Induce Changes in Hepatic Paraoxonase and ApoJ but Not Monocyte Chemoattractant Protein-1 via Interleukin-6
  Published by Elsevier ,2001
• C-Reactive Protein as a Cardiovascular Risk Factor
  Circulation, 1999
• Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different From That Required for Its Arylesterase/Paraoxonase Activities
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1998
• Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
  Journal of Clinical Investigation, 1998
• Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
  Journal of Clinical Investigation, 1995
• Atherosclerosis: Basic Mechanisms
  Circulation, 1995
• Influence of serum amyloid A protein on high-density lipoprotein in chronic inflammatory disease
  Clinical Biochemistry, 1993
• Human and rabbit paraoxonases: Purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification
  Chemico-Biological Interactions, 1993
• Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis
  American Heart Journal, 1987